Lisata Therapeutics Inc. (LSTA)
NASDAQ · Healthcare
Lisata Therapeutics Inc. EBITDA 2010–2025
Lisata Therapeutics Inc. annual/quarterly ebitda history and growth rate from 2010 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Lisata Therapeutics Inc. ebitda for the quarter ending March 31, 2026 was -4.9 M, a 14.89% decrease year-over-year.
- Lisata Therapeutics Inc. ebitda for the twelve months ending March 31, 2026 was -19.9 M, a 17.35% decrease year-over-year.
- Lisata Therapeutics Inc. annual ebitda for 2025 was -18.1 M, a 18.76% decrease from 2024.
- Lisata Therapeutics Inc. annual ebitda for 2024 was -22.2 M, a 12.87% decrease from 2023.
- Lisata Therapeutics Inc. annual ebitda for 2023 was -25.5 M, a 55.64% decrease from 2022.
- Lisata Therapeutics Inc. annual ebitda for 2022 was -57.5 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lisata Therapeutics Inc. EBITDA — FAQ
Lisata Therapeutics Inc. (LSTA) ebitda over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LSTA's ebitda history?
The chart and table above show Lisata Therapeutics Inc.'s ebitda by year and by quarter, including the growth rate.